Liver diseases, both acute and chronic, continue to pose significant clinical challenges due to high morbidity and mortality rates.
HMGB1 as a key mediator in liver disease pathogenesis
- Post author:
- Post published:November 8, 2024
- Post category:uncategorized
- Post comments:0 Comments